Sheets Smith Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Sell
17,231
-462
-3% -$158K 0.62% 40
2026
Q1
$6.23M Buy
17,693
+38
+0.2% +$13.5K 0.7% 34
2025
Q4
$5.78M Sell
17,655
-1,626
-8% -$516K 0.63% 39
2025
Q3
$5.44M Sell
19,281
-315
-2% -$91.4K 0.62% 39
2025
Q2
$5.47M Sell
19,596
-167
-0.8% -$47.3K 0.64% 41
2025
Q1
$6.16M Sell
19,763
-686
-3% -$203K 0.77% 31
2024
Q4
$5.33M Sell
20,449
-243
-1% -$72.1K 0.65% 39
2024
Q3
$6.67M Buy
20,692
+4,745
+30% +$1.55M 0.82% 34
2024
Q2
$4.98M Buy
15,947
+2,947
+23% +$866K 0.6% 41
2024
Q1
$3.7M Buy
13,000
+210
+2% +$61.4K 0.41% 62
2023
Q4
$3.68M Sell
12,790
-520
-4% -$142K 0.52% 50
2023
Q3
$3.58M Buy
13,310
+10
+0.1% +$2.5K 0.54% 48
2023
Q2
$2.95M Buy
13,300
+38
+0.3% +$8.82K 0.43% 58
2023
Q1
$3.21M Sell
13,262
-154
-1% -$37.8K 0.49% 50
2022
Q4
$3.52M Sell
13,416
-3
-0% -$804 0.55% 50
2022
Q3
$3.02M Sell
13,419
-120
-0.9% -$29.1K 0.51% 52
2022
Q2
$3.29M Sell
13,539
-253
-2% -$62K 0.54% 51
2022
Q1
$3.33M Sell
13,792
-86
-0.6% -$19.8K 0.46% 55
2021
Q4
$3.12M Buy
13,878
+456
+3% +$96.2K 0.39% 66
2021
Q3
$2.85M Buy
13,422
+122
+0.9% +$28.1K 0.39% 63
2021
Q2
$3.24M Buy
13,300
+397
+3% +$97.7K 0.44% 57
2021
Q1
$3.21M Buy
12,903
+510
+4% +$122K 0.47% 55
2020
Q4
$2.85M Buy
12,393
+1,121
+10% +$258K 0.43% 66
2020
Q3
$2.87M Buy
11,272
+20
+0.2% +$4.96K 0.5% 59
2020
Q2
$2.65M Buy
11,252
+6,826
+154% +$1.56M 0.53% 52
2020
Q1
$897K Sell
4,426
-61
-1% -$13.3K 0.19% 119
2019
Q4
$1.08M Sell
4,487
-69
-2% -$15.2K 0.21% 116
2019
Q3
$882K Sell
4,556
-177
-4% -$34K 0.18% 134
2019
Q2
$872K Sell
4,733
-90
-2% -$16.1K 0.18% 140
2019
Q1
$916K Sell
4,823
-58
-1% -$11.1K 0.2% 133
2018
Q4
$950K Sell
4,881
-27
-0.6% -$5.27K 0.26% 98
2018
Q3
$1.02M Buy
4,908
+3
+0.1% +$591 0.21% 119
2018
Q2
$905K Sell
4,905
-102
-2% -$18K 0.21% 117
2018
Q1
$854K Buy
5,007
+24
+0.5% +$4.41K 0.21% 130
2017
Q4
$867K Buy
4,983
+151
+3% +$26.7K 0.2% 133
2017
Q3
$901K Sell
4,832
-179
-4% -$31.7K 0.23% 119
2017
Q2
$863K Buy
5,011
+4
+0.1% +$651 0.23% 125
2017
Q1
$821K Buy
5,007
+3,398
+211% +$565K 0.22% 133
2016
Q4
$235K Hold
1,609
0.07% 253
2016
Q3
$268K Hold
1,609
0.08% 222
2016
Q2
$245K Sell
1,609
-144
-8% -$22.4K 0.07% 219
2016
Q1
$263K Buy
1,753
+1
+0.1% +$149 0.08% 198
2015
Q4
$284K Hold
1,752
0.09% 185
2015
Q3
$242K Buy
1,752
+1
+0.1% +$158 0.08% 184
2015
Q2
$269K Hold
1,751
0.07% 201
2015
Q1
$280K Sell
1,751
-499
-22% -$78.6K 0.08% 194
2014
Q4
$358K Buy
2,250
+100
+5% +$15.6K 0.09% 186
2014
Q3
$302K Hold
2,150
0.08% 192
2014
Q2
$254K Hold
2,150
0.07% 220
2014
Q1
$265K Hold
2,150
0.07% 203
2013
Q4
$245K Hold
2,150
0.07% 225
2013
Q3
$241K Buy
+2,150
New +$233K 0.08% 211

Other funds holding AMGN

Sheets Smith Wealth Management's AMGN Position: Q2 2026 in Review

Sheets Smith Wealth Management reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $158K and leaving 17,231 shares worth $6.24M. The position accounts for 0.62% of the portfolio, ranked #40.

Sheets Smith Wealth Management first reported a position in AMGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $6.67M in Q3 2024. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sheets Smith Wealth Management held 17,231 shares of Amgen worth $6.24M as of Q2 2026.
  • Sheets Smith Wealth Management sold 462 Amgen shares in Q2 2026, an estimated $158K.
  • Amgen made up 0.62% of Sheets Smith Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Sheets Smith Wealth Management first reported a position in Amgen in Q3 2013 and has held it in 52 quarters since.
  • Sheets Smith Wealth Management's Amgen position peaked at $6.67M in Q3 2024.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.